Chinese and foreign health products fight "plant war"

Ginkgo biloba extract, bilberry extract, ginseng extract Recently, the "plant extract" which has been popular all over the world has international business standards, and the listed companies participating in the formulation may benefit from it, and the sales will be more "promising" According to the statistics, the export volume of plant extract in the first quarter of 2013 is as high as 330 million US dollars, accounting for 47% of the export volume of Chinese medicine, while the United States has been ranked first in the export volume of plant extract in China for many years Export: it is understood that the plant extract industry is a sunrise industry with rapid development In the field of Chinese herbal medicine export, the plant extract industry has grown rapidly in recent years, and the export growth rate is far higher than that of traditional Chinese herbal medicine, all of which is related to more and more countries begin to favor nutrition and health care products Taking the United States as an example, in the trade of traditional Chinese medicine between China and the United States, the main part is the export of extract from China to the United States Licorice extract, including licorice extract, glycyrrhizinate and other licorice products, is the largest plant extract product exported from China to the United States The consumption market of nutrition and health care products in the United States is huge, and the market grows at the rate of 20% every year Influenced by factors such as farmers' planting habits and production costs, the output of medicinal plants in the United States can only meet 25% of its production demand, and the rest of raw materials and medicines are imported After entering the international market, some of China's plant extracts are provided to the local as plant medicine or dietary supplement, and some of them may be processed into "foreign traditional Chinese medicine" with higher added value for domestic sale "Like ginkgo biloba's plant extract health care products, they are becoming popular at home and abroad Germany is developing rapidly in this respect Some enterprises handle 800 tons of Ginkgo biloba raw materials in the whole year "One industry observer said Market: favored by middle-aged and elderly people, reporters visited Guangzhou drugstores and visited taobao.com and found that all kinds of Chinese and Western "traditional Chinese medicine health products" are popular, especially aloe, ginkgo, bilberry, grape seed, ginseng, rose fruit, a variety of plant extract compounds and other types of health products are hot, and most of them are expensive, the mainstream price is between 100-600 yuan / bottle "Health products have been popular, such as deep sea fish oil, collagen, spirulina and other elements, while plant extracts really belong to the rare type of" universal killing at home and abroad " "A marketing manager of a drugstore in Guangzhou told our reporter that because he plays the plant brand, he feels natural and has few side effects, and many plants have been proved to have certain effect on the prevention and health care of various diseases, so the market feedback is very good, the sales are increasing year by year, and the middle-aged and elderly are the main consumers However, industry insiders also pointed out that in the emerging field of plant extract health care products, Chinese and foreign enterprises are fighting fiercely, which can be described as a close fight The advantages of Chinese and foreign enterprises are also quite different: "many foreign giants have advantages in technology and patents, because Chinese medicine products are still relatively sensitive, while foreign enterprises can often be in the extraction and separation process, product function mechanism and safety evaluation It's just the main disadvantage of domestic pharmaceutical enterprises to be ahead in other aspects, but Chinese traditional medicine enterprises have the advantage of "local advantages" Unfortunately, it's not easy for Chinese traditional medicine enterprises to "break through" in foreign countries at present "He said Good news: listed companies will benefit from the implementation of plant extract standards According to the introduction of China Chamber of Commerce for the import and export of medical and health products, the first batch of international business standards for plant extract has been released recently and will be officially implemented from October 1 The reporter understands that Rhine bio is one of the participants in the standard setting, and many listed companies may benefit from the new standard setting "The establishment of this standard will create a good growth environment for the industry of plant extraction, especially for high-quality enterprises, which will obtain the" price discourse right "and" pricing right ", making these enterprises more active in the trade of plant extracts," the Commission of plant extraction standards of the chamber of Commerce previously disclosed "Among the seven international business standards for plant extracts issued this time, the international business standard for Ginkgo biloba extract is the highest international standard at present, even higher than the same kind of plant extraction standards of the European Union and the United States, which will also increase a lot of weight for China's plant extracts to go abroad The reporter noted that the listed companies related to plant extracts include ANGLI, Chenguang biology, Kangenbei, Rhine biology, Tianshili, Yunnan Baiyao, Baiyunshan, etc "These listed companies are all powerful and high-quality companies with relatively rich product lines Some of them also have exclusive varieties of traditional Chinese medicine that have entered the catalogue of basic drugs, so they should have strong strength in R & D and other aspects Some of them are located in the planting and processing bases of traditional Chinese medicine, and have a strong foundation in the source of raw materials "A pharmaceutical industry analyst said that if investors are interested in plant extract content, they can choose relevant stocks to pay attention to it.